Monica Salamea, n/a

SVP, Clinical Operations
Ambros Therapeutics, Inc, United States

Presentation(s):

• Pivotal phase 3 trial of neridronate in Complex Regional Pain Syndrome Type 1: CRPS-RISE study design and methodology

  Thursday, November 13, 2025
  9:19 AM - 9:27 AM CT

  Disclosure information not submitted.